Advanced Search
Contact | Corporate | Help

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

Sponsors:
  • Weill Medical College of Cornell University
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Idiopathic Thrombocytopenic Purpura (ITP)
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Rituximab
Enrollment:

Additional information about NCT00161564.


SourceSolution © 2008-2012